On May 28, 2025, Elevance Health, Inc. indicated to investors that they expect full year 2025 earnings guidance to be $28.30 to $29.00 per diluted share, reaffirming an adjusted earnings estimate of $34.15 to $34.85 per diluted share. They also forecast a benefit expense ratio of 89.1%, plus or minus 50 basis points.